AbbVie’s $1.4 Billion Acquisition of Aliada Therapeutics

Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics.AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into a…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here